CVS Health Corp vs Sirius XM Holdings Inc — how do they compare? CVS Health Corp trades at $86.3 (market cap $112.49B), while Sirius XM Holdings Inc trades at $26.52 (market cap $8.75B). The key difference: CVS Health Corp is far larger — about 12.9× Sirius XM Holdings Inc's market cap, and Sirius XM Holdings Inc pays the higher dividend (4.16%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Sirius XM Holdings Inc for 102 Days on average.
| CVS | SIRI | |
|---|---|---|
Market Cap | $112.49B | $8.75B |
Volume | 8,467,392 | 4,004,963 |
Sector | Health | Media |
52-Week High | $110.60 | $32.59 |
52-Week Low | $70.08 | $19.92 |
Typical Hold Time | 83 Days | 102 Days |
Enterprise Value | $174.83B | $18.03B |
Dividend Yield | 3.02% | 4.16% |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
Sirius XM (SIRI) trades at $25.95, down 1.56% with bearish technical signals despite strong analyst support. The company shows mixed earnings performance with Q1 2026 beating expectations but Q2 2026 missing. Fundamentals reveal solid profitability with 10.23% net margin and attractive valuation at P/E of 10.42. Recent developments include a YouTube partnership and strong cash flow growth highlighted in recent conferences.
The stock presents a value opportunity with significant upside to the $34.43 consensus target, though technical weakness and competitive pressures in audio streaming warrant caution. Strong institutional buying and dividend payments provide support, but execution on advertising growth remains critical for sustained appreciation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →